Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey
Author(s) -
Berna İmge Aydoğan,
Bağdagül Yüksel,
Mazhar Müslüm Tuna,
Mehtap Navdar Başaran,
Ayşen Akkurt,
Melek Eda Ertörer,
Kadriye Aydın,
Sibel Güldiken,
Yasin Şimşek,
Züleyha Karaca,
Merve Yılmaz,
Müjde Aktürk,
İnan Anaforoğlu,
Nur Kebapçı,
Cevdet Duran,
Abdullah Taşlıpınar,
Mustafa Kulaksızoğlu,
Alptekin Gürsoy,
Selçuk Dağdelen,
Murat Faik Erdoğan
Publication year - 2016
Publication title -
journal of clinical research in pediatric endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.566
H-Index - 35
eISSN - 1308-5735
pISSN - 1308-5727
DOI - 10.4274/jcrpe.2219
Subject(s) - medicine , thyroidectomy , medullary cavity , thyroid carcinoma , multiple endocrine neoplasia type 2 , mutation , genetic testing , multiple endocrine neoplasia , calcitonin , retrospective cohort study , gastroenterology , pheochromocytoma , medullary thyroid cancer , oncology , thyroid , pediatrics , germline mutation , genetics , biology , gene
This retrospective multicenter study, centrally conducted and supported by the Society of Endocrinology and Metabolism of Turkey, aimed to evaluate the impact of free RET proto-oncogene testing in medullary thyroid carcinoma (MTC) patients. Surgical timing, adequacy of the treatment, and frequency of prophylactic thyroidectomy (PTx) in mutation carriers were also assessed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom